Based on the Diversified Healthcare Trust stock forecast from 1 analysts, the average analyst target price for Diversified Healthcare Trust is USD 6.00 over the next 12 months. Diversified Healthcare Trust’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Diversified Healthcare Trust is Slightly Bullish , which is based on 10 positive signals and 6 negative signals. At the last closing, Diversified Healthcare Trust’s stock price was USD 2.56. Diversified Healthcare Trust’s stock price has changed by -10.96% over the past week, -30.43% over the past month and +29.95% over the last year.
No recent analyst target price found for Diversified Healthcare Trust
No recent average analyst rating found for Diversified Healthcare Trust
Company Overview Diversified Healthcare Trust
DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. Read Less
DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by p...Read More
Frequently Asked Questions About Diversified Healthcare Trust (DHC) Stock
Based on ratings from 1 analysts Diversified Healthcare Trust's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
DHC stock's dividend yield is 1.11%.
Our analysis grades DHC stock's dividend yield at F. This means that DHC stock's dividend yield is above 25% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this DHC may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for DHC is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.
DHC stock's Price/Earning ratio is 0.56.
Our analysis grades DHC stock's Price / Earning ratio at A+. This means that DHC stock's Price/Earning ratio is above 0% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this DHC may be undervalued for its sector.
The last closing price of DHC's stock was USD 2.56.
The most recent market capitalization for DHC is USD 0.86B.
Based on targets from 1 analysts, the average taret price for DHC is projected at USD 6.00 over the next 12 months.
This means that DHC's stock price may go up by +134.38% over the next 12 months.
We can't find any ETFs which contains Diversified Healthcare Trust's stock.
As per our most recent records Diversified Healthcare Trust has 0 Employees.
Diversified Healthcare Trust's registered address is Two Newton Place, Newton, MA, United States, 02458-1634.
You can get more information about it from Diversified Healthcare Trust's website at https://www.dhcreit.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Diversified Healthcare Trust (DHC) Stock
Based on ratings from 1 analysts Diversified Healthcare Trust's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
DHC stock's dividend yield is 1.11%.
Our analysis grades DHC stock's dividend yield at F. This means that DHC stock's dividend yield is above 25% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this DHC may be a poor dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for DHC is USD 6.00 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 6.
DHC stock's Price/Earning ratio is 0.56.
Our analysis grades DHC stock's Price / Earning ratio at A+. This means that DHC stock's Price/Earning ratio is above 0% of the stocks in the REIT - Healthcare Facilities sector in the NSD exchange.
Based on this DHC may be undervalued for its sector.
The last closing price of DHC's stock was USD 2.56.
The most recent market capitalization for DHC is USD 0.86B.
Based on targets from 1 analysts, the average taret price for DHC is projected at USD 6.00 over the next 12 months.
This means that DHC's stock price may go up by +134.38% over the next 12 months.
We can't find any ETFs which contains Diversified Healthcare Trust's stock.
As per our most recent records Diversified Healthcare Trust has 0 Employees.
Diversified Healthcare Trust's registered address is Two Newton Place, Newton, MA, United States, 02458-1634.
You can get more information about it from Diversified Healthcare Trust's website at https://www.dhcreit.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DHC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
